GreenRoc Accelerates their World Class Project to Production as Early as 2028. Watch the full video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYGEN.L Regulatory News (YGEN)

  • There is currently no data for YGEN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Independent Analysis of Permian Well results

17 Feb 2010 07:41

RNS Number : 2644H
ViaLogy PLC
17 February 2010
 



VIALOGY PLC

 

INDEPENDENT ANALYSIS VERIFIES VIALOGY

PERMIAN WELL PREDICTIONS

 

London, February 17. ViaLogy (LSE:VIY) announces the start of oil production from a recently completed successful well in the Strawn formation in Texas, and independent confirmation of ViaLogy's reservoir attribute predictions. The client specified that ViaLogy find Strawn with significant thickness to make a commercially successful well; that major zones of porosity over 4% be identified; and that the selected Strawn section exhibit natural fracturing to enable optimal production.

Final well and formation micro-imaging (FMI) logs, done by Halliburton, show that QuantumRD directly detected and predicted a 220 foot continuous Strawn section. Within this section, ViaLogy's pre-drilling analysis located high porosity limestone zones - totaling over 80 feet with more than 4% porosity. Logging showed a continuous zone of 50 feet with greater than 6% porosity, and reaching 10 to 12%. The ability of the technology to find and distinguish between such small variations in limestone porosity demonstrates QuantumRD's sensitivity, and its utility in mapping the Strawn and other formations where porosity is a critical factor in determining a well's economic viability. In addition, the analysis also verified that QuantumRD located natural fractures enhancing the reservoir's permeability and enabling extraction to be optimized. ViaLogy's contract prohibits identifying the client.

This ViaLogy-positioned well is in the Permian Basin, one of the largest structural basins and most prolific petroleum provinces in North America, extending approximately 86,000 sq miles over Texas and New Mexico. It sits in the naturally fractured Spraberry Trend Area in west Texas covering approximately 2,500 square miles over a six county area. Estimated to hold 6-10 billion bbls of oil, this trend area has huge potential for future recovery as only about 700 million bbls have been produced over the past 50 years. This is due in part to the analytical challenges of finding high porosities and developing economically viable wells in the carbonate, limestone and/or dolomite platform, and to natural fractures in a rock matrix with inherently low permeability. Also, unlike conventional faulted sandstone reservoirs, the Permian platform is a stratigraphic formation with discontinuities over small areas. Current exploration technologies and basin geology models provide limited insight for positioning individual wells and offsets, as the formation properties change unpredictably due to complex cementation and matrix dissolution processes. QuantumRD's more innovative computational approach to characterize the subsurface and locate drilling targets should assist in the Permian Basin's exploitation.

Robert Dean, ViaLogy CEO, said, "Independent confirmation of QuantumRD's Strawn success further validates the technology's power. ViaLogy's work is done on the basis of specific client drilling requirements - they tell us what quantifiable characteristics to find, such as porosity, and this can vary depending upon the location, formation characteristics and land area where a client wants to drill. We offer an 'energy solution' - the ability to identify drilling sites, depths, porosities and trends based on a synergistic integration of rock physics, 3-D and multi-component seismic data, and depositional geology. In this well we used QuantumRD, our proprietary weak signal detection technology, to locate regions of high porosity within a range of carbonate sizes that are key for positioning successful Permian wells."

He added, "Our technology can be applied to virtually any hydrocarbon formation, and we have a growing customer list and backlog that will take us into other areas of the Permian and other completely different areas. We are now finalizing our next drilling recommendation location on this particular Strawn prospect, and we intend to deliver another success to our client. We are also in discussions with several exploration & production firms to deliver QuantumRD analysis on the Permian."

 

ViaLogy PLC

 

Robert W Dean, President & CEO - US +1 626-296-6337 (mobile: +1 703-589-3807)

Terry Bond, Chairman - UK & Europe +44 (0) 1235-834734 (mobile: 07860 842756)

 

 

Nominated Advisor to ViaLogy PLC (Seymour Pierce)

Mark Percy +44 (0) 20-7107-8000

 

 

About ViaLogy: Network Centric Signal Processing

ViaLogy is a leading innovator of network-centric, real-time signal processing platforms for sensor applications. ViaLogy is currently deploying and designing computational systems, powered by its patented technologies, for applications in life sciences, public safety and security, surveillance, defense and geoseismology. ViaLogy focuses on market driven problems where automation, timeliness, quality and reliability of information processing are essential. ViaLogy's core competency incorporates rapidly and accurately detecting weak signals buried in high noise background and clutter. This technology can be employed to solve problems involving sensor integration and information overload challenges involving video, telephony and control sensors, as well as for enhancement of numerous signal processing applications. For more information, visit our website at www.ViaLogy.com.

 

 

Except for statements of historical fact, the information presented herein constitutes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results,

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DRLDDLBFBLFXBBK
Date   Source Headline
1st Apr 201912:12 pmRNSHolding(s) in Company
25th Mar 20197:00 amRNSYourgene raises IONA® test awareness in Egypt
26th Feb 20193:21 pmRNSHolding(s) in Company
22nd Feb 201910:00 amEQSHardman & Co Research: Yourgene Health (YGEN): EBITDA-positive in fiscal 2020
22nd Feb 20198:05 amRNSHolding(s) in Company
19th Feb 20192:21 pmRNSHolding(s) in Company
19th Feb 20197:15 amEQSHardman & Co Research: Yourgene Health (YGEN): Transformed and de-risked
18th Feb 201910:59 amRNSIssue of Equity
18th Feb 20197:00 amRNSMajor Capital & Commercial Restructuring
8th Jan 20197:00 amRNSYourgene launches Sage 32 plex
3rd Dec 20187:00 amRNSHalf-year Results
7th Nov 20187:00 amRNSChange of Name to Yourgene Health plc
5th Nov 201811:24 amRNSShare Transfer
2nd Nov 20187:00 amRNSDirectorate Change
25th Oct 20183:30 pmRNSResult of AGM
25th Oct 20187:00 amRNSHolding(s) in Company
25th Oct 20187:00 amRNSAGM Statement
22nd Oct 20187:00 amRNSFurther re: Fundraise
12th Oct 20181:15 pmRNSAvailability of Research Commentary
12th Oct 20187:00 amRNSTrading Update and Notice of Results
5th Oct 20187:00 amRNSDirector's dealing and share option issue
4th Oct 20187:00 amRNS$1 million collaboration agreement
3rd Oct 20187:00 amRNSDirectorate change
2nd Oct 20187:00 amRNSNotice of AGM
1st Oct 201812:20 pmRNSResult of Fundraise
28th Sep 20185:41 pmRNSProposed fundraise to raise approximately £2.5m
28th Sep 20185:40 pmRNSFull year results and half-year trading update
25th Sep 201811:31 amRNSHolding(s) in Company
21st Sep 20184:10 pmRNSHolding(s) in Company
21st Sep 20187:00 amRNSHolding(s) in Company
20th Sep 20189:30 amRNSSenior Appointment & Anticipated Director Change
19th Sep 201811:05 amRNSSecond Price Monitoring Extn
19th Sep 201811:00 amRNSPrice Monitoring Extension
19th Sep 20187:00 amRNSLegal Settlement & Licence Agreement with Illumina
11th Sep 20187:00 amRNSHolding(s) in Company
7th Aug 201810:57 amRNSHolding(s) in Company
12th Jul 20187:00 amRNSShare option awards
4th Jul 20187:00 amRNSBoard Changes
26th Jun 20181:31 pmRNSCollaboration with Abnova
13th Jun 20187:00 amRNSOutstanding NIPS Solution Provider Award Win
11th Jun 20187:00 amRNSDNA sequencing technology development agreement
7th Jun 20183:44 pmRNSHolding(s) in Company
5th Jun 20187:00 amRNSPremaitha signs partnership agreement in India
4th Jun 201811:05 amRNSHolding(s) in Company
24th May 20187:00 amRNSHolding(s) in Company
18th May 20184:38 pmRNSHolding(s) in Company
18th May 201812:06 pmRNSHolding(s) in Company
18th May 201812:05 pmRNSHolding(s) in Company
18th May 20189:40 amRNSHoldings in Company
15th May 20187:00 amRNSPremaitha expands footprint with new laboratories

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.